Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility

Although infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SA-RVS) have been reported from a number of countries, including Australia, the optimal therapy is unknown. We reviewed the clinical features, therapy, and outcome of 25 patients with se...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2004-02, Vol.38 (4), p.521-528
Hauptverfasser:	Howden, Benjamin P., Ward, Peter B., Charles, Patrick G. P., Korman, Tony M., Fuller, Andrew, du Cros, Philipp, Grabsch, Elizabeth A., Roberts, Sally A., Robson, Jenny, Read, Kerry, Bak, Narin, Hurley, James, Johnson, Paul D. R., Morris, Arthur J., Mayall, Barrie C., Grayson, M. Lindsay
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - therapeutic use Aged Aged, 80 and over Anti-Infective Agents - therapeutic use Antibiotics Arthritis Bacteremia Bacterial diseases Biological and medical sciences Cardiology. Vascular system Diabetes mellitus Endocardial and cardiac valvular diseases Endocarditis Female Glycopeptides Heart Human bacterial diseases Humans Infections Infectious diseases Linezolid Major Articles Male Medical sciences Methicillin Resistance Methicillin resistant staphylococcus aureus Microbial Sensitivity Tests Middle Aged Ovulation method Oxazolidinones - therapeutic use Rifampin - therapeutic use Staphylococcal Infections - drug therapy Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcus aureus Staphylococcus aureus - drug effects Treatment Outcome Vancomycin Vancomycin Resistance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!